Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ardent Health (ARDT) Enterprise Value (2024 - 2026)

Ardent Health has reported Enterprise Value over the past 3 years, most recently at -$710.9 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$710.9 million for Q4 2025, down 27.94% from a year ago — trailing twelve months through Dec 2025 was -$710.9 million (down 27.94% YoY), and the annual figure for FY2025 was -$710.9 million, down 27.94%.
  • Enterprise Value for Q4 2025 was -$710.9 million at Ardent Health, down from -$610.9 million in the prior quarter.
  • Over the last five years, Enterprise Value for ARDT hit a ceiling of -$184.5 million in Q3 2024 and a floor of -$710.9 million in Q4 2025.
  • Median Enterprise Value over the past 3 years was -$518.8 million (2025), compared with a mean of -$482.6 million.
  • Peak annual rise in Enterprise Value hit 27.94% in 2025, while the deepest fall reached 231.07% in 2025.
  • Ardent Health's Enterprise Value stood at -$430.3 million in 2023, then dropped by 29.13% to -$555.6 million in 2024, then dropped by 27.94% to -$710.9 million in 2025.
  • The last three reported values for Enterprise Value were -$710.9 million (Q4 2025), -$610.9 million (Q3 2025), and -$542.4 million (Q2 2025) per Business Quant data.